Digital & Innovation

Novartis and Microsoft collaborate to advance medicine with AI

Health Industry Hub | October 9, 2019 |
[Total: 1    Average: 5/5]

Novartis is launching an AI innovation lab and has selected Microsoft as its strategic AI and data-science partner. The new lab aims to enhance Novartis AI capabilities from research through commercialisation and accelerate the discovery and development of transformative medicines for patients worldwide.

“Our AI Innovation Lab will bring together the best in tech, with the best in Life Sciences here at Novartis to accelerate drug discovery and drug development for patients all around the world. The AI innovation lab was an idea Spark, in a conversation between Microsoft CEO Satya Nadella and myself about the common interest we both have in using science, technology and great people to dramatically improve problems facing humanity. You have to go big to tackle the greatest challenges of our time. And I’m excited about this partnership and the possibilities it holds to help us reimagine medicine.” said Vas Narasimhan, CEO of Novartis.

Novartis will initially focus on three key areas;

  • Generative chemistry – can AI and machine learning algorithms be used to suggest molecules with certain characteristics?
  • CAR-T cell therapy platform – using advanced analytics and AI to drive precision in cell and gene production.
  • Imaging – defining precision dosing of optical therapies for patients with optical coherence tomography (OCT) of the eye and the use of machine learning and AI.

To enhance patient outcomes with the application of AI in healthcare, the Pharmaceutiucal industry needs the ecosystem of partners, from big tech AI companies like Microsoft, to academic institutions and the start-up community who are innovating at the intersection of AI and its application to life sciences.

You may also like Demystifying AI, machine learning and robotics in healthcare


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Prime Minister’s Prize for Innovation awarded to cancer drug breakthrough

Health Industry Hub | October 21, 2019 |

The discovery and development of a breakthrough anti-cancer drug has seen four senior scientists from the Walter and Eliza Hall […]

More


News & Trends - Pharmaceuticals

Pharmacist prescribing on the way

Health Industry Hub | October 21, 2019 |

The Pharmaceutical Society of Australia (PSA) has welcomed the Pharmacy Board of Australia’s position statement on pharmacist prescribing which outlines the way […]

More


News & Trends - Medical Technology

Competitive grants to turn MedTech discoveries into clinical reality

Health Industry Hub | October 21, 2019 |

Cutting edge researchers and entrepreneurs can receive up to $1 million from the Morrison Government to develop their breakthrough medical […]

More


News & Trends - Pharmaceuticals

New discovery to reduce renal failure in patients with diabetic kidney disease

Health Industry Hub | October 21, 2019 |

Researchers from Monash University’s Central Clinical School in Australia have found that a drug that has already been tested on other […]

More